Evidence map›Paper›PMID 21474073›Full record

ArticleMolecular cell2011

Dot1 and histone H3K79 methylation in natural telomeric and HM silencing.

Yoh-Hei Takahashi, Julia M Schulze, Jessica Jackson, Thomas Hentrich, Chris Seidel, Sue L Jaspersen, Michael S Kobor, Ali Shilatifard

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 116 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. The 80Journal of microbiology and biotechnology · 2024
    Article
  8. Article
  9. Article
  10. A novel role of DOT1L in kidney diseases.Molecular biology reports · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Yoh-Hei TakahashiStowers Institute for Medical Research, 1000 East 50th Street, Kansas City, MO 64110, USA.
Julia M Schulze
Jessica Jackson
Thomas Hentrich
Chris Seidel
Sue L Jaspersen
Michael S Kobor
Ali Shilatifard
Stowers Institute for Medical Research · USUniversity of British Columbia · CASaint Louis University · US

Funding

Chromatin Modifications by Histone Ubiquitination and MethylationsR01GM069905 · NIGMS · STOWERS INSTITUTE FOR MEDICAL RESEARCH · PI SHILATIFARD, ALI · 2004 to 2015
$4.7M
Physiological Role of MLL and ELL Proteins in LeukemiaR01CA089455 · NCI · STOWERS INSTITUTE FOR MEDICAL RESEARCH · PI SHILATIFARD, ALI · 2001 to 2015
$3.5M
CIHR MOP-79442NCI NIH HHS R01 CA089455NIGMS NIH HHS R01 GM069905NIGMS NIH HHS R01GM069905
6 · The paper itself

Abstract

The expression of genes residing near telomeres is attenuated through telomere position-effect variegation (TPEV). By using a URA3 reporter located at TEL-VII-L of Saccharomyces cerevisiae, it was proposed that the disruptor of telomeric silencing-1 (Dot1) regulates TPEV by catalyzing H3K79 methylation. URA3 reporter assays also indicated that H3K79 methylation is required for HM silencing. Surprisingly, a genome-wide expression analysis of H3K79 methylation-defective mutants identified only a few telomeric genes, such as COS12 at TEL-VII-L, to be subject to H3K79 methylation-dependent natural silencing. Consistently, loss of Dot1 did not globally alter Sir2 or Sir3 occupancy in subtelomeric regions, but only led to some telomere-specific changes. Furthermore, H3K79 methylation by Dot1 did not play a role in the maintenance of natural HML silencing. Therefore, commonly used URA3 reporter assays may not report on natural PEV, and therefore, studies concerning the epigenetic mechanism of silencing in yeast should also employ assays reporting on natural gene expression patterns.

Indexed as

AcetyltransferasesChromosomal Position EffectsGenes, FungalGene SilencingGenome-Wide Association StudyHistone-Lysine N-MethyltransferaseHistonesMethylationN-Terminal Acetyltransferase ANuclear ProteinsSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsSilent Information Regulator Proteins, Saccharomyces cerevisiaeSirtuin 2TelomereAcetyltransferasesARD1 protein, S cerevisiaeDot1 protein, S cerevisiaeHistone-Lysine N-MethyltransferaseHistonesN-Terminal Acetyltransferase ANuclear ProteinsSaccharomyces cerevisiae ProteinsSilent Information Regulator Proteins, Saccharomyces cerevisiaeSIR2 protein, S cerevisiaeSIR3 protein, S cerevisiaeSirtuin 2

Identifiers

PMID21474073
PMCPMC3085244
OpenAlexW1992965842

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.